Joseph A Pinto (Joseph Pinto)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 12

Top Topics

Monoclonal Antibody

Small Cell Lung Cancer

Top Venues

Scientific reports

NPJ genomic medicine

Clinical Medicine Insights. Oncology

Microbiology resource announcements

This page only lists publications with an associated author ORCID identifier.

Publications

Jhajaira M Araujo, Gabriel De La Cruz Ku, Melanie Cornejo, Franco Doimi, Richard Dyer, Henry L Gomez, Joseph A Pinto
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes. Cancers 14 (17) (2022)
Maryanne M Gonzales Carazas, Joseph A Pinto, Fanny L Casado
Biological bases of cancer immunotherapy. Expert reviews in molecular medicine 23 (2021)
Luis A Salcedo-Mejía, Yerson Durán-Ramirez, Rodolfo Z Velazco-Peña, Joseph A Pinto, Alfredo Rebaza-Caballero
Near-Complete Genome Sequences of 12 Peruvian Strains of Infectious Hypodermal and Hematopoietic Necrosis Virus Infecting the Shrimp Penaeus vannamei. Microbiology resource announcements 10 (20) (2021)
Alexis Germán Murillo Carrasco, Oscar Acosta, Jaime Ponce, Jose M Cotrina, Alfredo Aguilar, Jhajaira M Araujo, Pamela Rebaza, Joseph A Pinto, Ricardo M Fujita, José Luis Buleje Sono
PUM1 and RNase P genes as potential cell-free DNA markers in breast cancer. Journal of clinical laboratory analysis 35 (4) (2021)
Joseph A Pinto, Luis E Raez, Gelenis Domingo
Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer. Expert review of respiratory medicine 14 (4) (2020)
Gabriel De La Cruz Ku, Diego Chambergo-Michilot, Bryan Valcarcel, Pamela Rebaza, Mecker Möller, Jhajaira M Araujo, Daniel Y Enriquez-Vera, Zaida Morante, Cesar Razuri, Renato Luque, Antonella Saavedra, Eduardo Eyzaguirre, Maria Lujan, Naysha Noel, Joseph A Pinto, Jose Cotrina, Henry L Gómez
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy. The breast journal 26 (9) (2020)
Joseph A Pinto, Luis E Raez, Helena Oliveres, Christian C Rolfo
Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer. Expert opinion on biological therapy 19 (6) (2019)
César H Saravia, Claudio Flores, Luis J Schwarz, Leny Bravo, Jenny Zavaleta, Jhajaira M Araujo, Silvia Neciosup, Joseph A Pinto
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer. Clinical Medicine Insights. Oncology 13 (2019)
Marco Gálvez-Nino, Rossana Ruiz, Joseph A Pinto, Kátia Roque Perez, Raul Mantilla, Luis E Raez, Luis Mas
Lung Cancer in the Young. Lung 198 (1) (2019)
Jhajaira M Araujo, Andrea C Gomez, Alfredo Aguilar, Roberto Salgado, Justin M Balko, Leny Bravo, Franco Doimi, Denisse Bretel, Zaida Morante, Claudio Flores, Henry L Gomez, Joseph A Pinto
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer. Scientific reports 8 (1) (2018)
Joseph A Pinto, Christian C Rolfo, Luis E Raez, Alexandra Prado, Jhajaira M Araujo, Leny Bravo, Williams Fajardo, Zaida D Morante, Alfredo Aguilar, Silvia P Neciosup, Luis A Mas, Denisse Bretel, Justin M Balko, Henry L Gomez
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies. Scientific reports 7 (1) (2017)
Joseph A Pinto, Jhajaira Araujo, Nadezhda K Cardenas, Zaida Morante, Franco Doimi, Tatiana Vidaurre, Justin M Balko, Henry L Gomez
A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease. NPJ genomic medicine 1 (2016)